We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

BRUKER

BRUKER offers high-performance scientific instruments and high-value analytical and diagnostic solutions that enable ... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Cutaneous Leishmaniasis Species Identified by Mass Spectrometry

By LabMedica International staff writers
Posted on 18 Jun 2014
Print article
Image: The BrukerAutoflex MALDI-TOF mass spectrometer (Photo courtesy of Bruker-Daltonics).
Image: The BrukerAutoflex MALDI-TOF mass spectrometer (Photo courtesy of Bruker-Daltonics).
Image: Cutaneous Leishmaniasis lesion on the hand (Photo courtesy of D.S. Martin).
Image: Cutaneous Leishmaniasis lesion on the hand (Photo courtesy of D.S. Martin).
Cutaneous leishmaniasis (CL) is caused by several Leishmania species that are associated with variable outcomes before and after therapy and optimal treatment decision is based on an accurate identification of the infecting species.

Current methods to type Leishmania isolates are relatively complex and slow and therefore, the initial treatment decision is generally presumptive, the infecting species being suspected on epidemiological and clinical grounds. A simple method to type cultured isolates would facilitate disease management.

Scientists at the University Pierre et Marie Curie (Paris, France) performed parasitological diagnosis and analysis by lesion scraping, biopsy or aspirate followed by direct examination of Giemsa-stained smears, histological analysis, Giemsa-stained tissue sections, culture or polymerase chain reaction (PCR). They also analyzed promastigote pellets from 46 strains cultured in monophasic medium, including 20 short-term cultured isolates from French travelers, 19 with CL, and one with visceral leishmaniasis and clinical isolates were analyzed in parallel with Multilocus Sequence Typing (MLST).

The promastigote pellets were analyzed by Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) technology and performed on a BrukerAutoflex I MALDI-TOF mass spectrometer (Bruker-Daltonics, Bremen, Germany). Automatic dendrogram analysis generated a classification of isolates consistent with reference determination of species based on MLST or 70 kDa heat shock protein gene (hsp70) sequencing. An analysis of the spectra, based on a very simple, database-independent analysis of spectra, showed that the mutually exclusive presence of two pairs of peaks discriminated isolates considered by reference methods to belong either to the Viannia or Leishmania subgenus, and that within each subgenus presence or absence of a few peaks allowed discrimination to species complexes level.

The authors concluded that analysis of cultured Leishmania isolates using mass spectrometry allows a rapid and simple classification to the species complex level consistent with reference methods, a potentially useful method to guide treatment decision in patients with cutaneous leishmaniasis. The intuitive interpretation of spectra was well-suited for allowing for close interactions between parasitologists and clinicians. The study was published on June 5, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University Pierre et Marie Curie
Bruker-Daltonics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.